EGFR and non-small cell lung carcinoma: Thus, these results suggested curcumin sensitized gefitinib and overcame the gefitinib resistance in modulating EGFR or other oncogenic proteins stability might similar to the actions of the Hsp90 inhibitor in which contributed to the NSCLC therapy (Figure 8).